Try our beta test site
3 studies found for:    "RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Open Studies | "Liver Diseases"
Show Display Options
Rank Status Study
1 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Interventions: Drug: Elafibranor;   Drug: Placebo
2 Recruiting Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction
Conditions: Advanced Solid Neoplasm;   Hepatic Complication;   Metastatic Malignant Neoplasm in the Liver;   Metastatic Solid Neoplasm;   Unresectable Solid Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Trametinib
3 Recruiting Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: sorafenib tosylate;   Radiation: stereotactic body radiation therapy

Study has passed its completion date and status has not been verified in more than two years.